Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which pain block is best after breast surgery? new study aims to find out

NCT ID NCT07502846

Symptom relief Sponsor: Başakşehir Çam & Sakura City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two types of nerve blocks (superficial vs. deep) for pain relief after breast surgery. 58 women will receive one of the two blocks, and researchers will measure how much pain medication they need in the first 24 hours. The goal is to find which block provides better pain control and reduces opioid use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If one block works better, it could mean less pain and less need for strong painkillers after breast surgery.
What could go wrong
This is a small, early-stage study with only 58 people, so results may not apply to everyone. Both blocks are already used, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 58 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients aged 18-75 years * ASA physical status I-III * Patients scheduled for elective mammoplasty surgery (unilateral or bilateral) * Patients who voluntarily agree to participate in the study and provide informed consent Exclusion Criteria: * ASA physical status IV or higher * Patients who refuse to participate in the study * Patients who cannot provide informed consent due to language barriers * Pregnant patients * Active infection at the block application site * Previous surgery affecting the anatomical integrity of the block area * Known allergy to local anesthetic agents * Patients with chronic pain or regular analgesic use * Patients with coagulation disorders * Patients with neurological or psychiatric disorders affecting pain perception or those using regular antipsychotic or antidepressant medications * Body mass index (BMI) \> 40 kg/m²

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Analgesia, postoperative are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Analgesia, postoperative Breast surgery Mammoplasty patient Opioid consumption Postoperative pain management

Contacts and locations

Locations

  • Başakşehir Çam & Sakura City Hospital

    Istanbul, Basaksehir, 34480, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.